{"filings":[{"id":591679,"accession_number":"0001759655-26-000034","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2026-05-22T12:00:45+00:00","items":["5.07"],"status":"ready","headline":"Privia Health shareholders elect all three Class I directors at 2026 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Nancy Cocozza, David King, and Francis Soistman elected as Class I directors with over 99M votes each.","Advisory vote on named executive officer compensation passed with ~103.96M for, 1.81M against.","Ratification of PwC as auditor for FY 2026 approved with ~117.34M for, 8,578 against.","Broker non-votes of 11,549,510 on director election and say-on-pay proposals; none on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95257,"accession_number":"0001759655-26-000027","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Privia Health Q1 revenue $603.8M (+25.8% YoY); adj EPS $0.19 (+18.8%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $603.8M (+25.8% YoY); gross profit $125.6M (+21.2%).","GAAP net income $3.1M ($0.02 EPS) vs $4.2M ($0.03) in Q1 2025.","Non-GAAP adjusted net income $24.3M ($0.19 adj EPS), up 22.3% YoY.","Operating income $7.4M, +42.2% YoY; reiterated full-year 2026 guidance.","Non-cash stock comp of $21.9M included in net income, up from $17.8M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":603847000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108176,"accession_number":"0001759655-26-000007","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2026-02-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Privia Health beats 2025 guidance; revenue $2.12B, net income +59%, Adj. EBITDA $125.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year revenue $2,122.8M, up 22.3% YoY; net income $22.9M, up 59.3% from 2024.","Adjusted EBITDA $125.5M, +38.8% YoY; net cash from operations $163.4M, +49.5%.","Year-end cash $479.7M, no debt; all 2025 metrics at or above high end of guidance.","2026 guidance: ~20% adjusted EBITDA growth at midpoint, implying ~$150.6M.","Non-GAAP adjusted EPS $0.99, up 26.9% YoY; GAAP EPS $0.18, up 63.6%."],"consensus_eps_estimate":null,"consensus_eps_actual":0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":2122842000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124606,"accession_number":"0001759655-25-000113","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2025-12-08T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Privia Health Group completes acquisition of Accountable Care Organization from Evolent Health","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Privia Health Group closed the acquisition of an Accountable Care Organization business from Evolent Health on December 5, 2025.","The definitive agreement was originally announced on September 23, 2025.","The transaction closed as scheduled, with no material changes from the earlier disclosure.","Privia Health Group will integrate the acquired ACO business into its operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124605,"accession_number":"0001759655-25-000108","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Privia Health Q3 net income surges 94%, revenue up 32.5%; raises FY25 guidance above high end","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $580.4M (+32.5% YoY); net income $6.9M (+94.1%); operating income $14.4M (+147.8%).","Non-GAAP adjusted net income $37.3M (+49.1%); adjusted EPS $0.29 vs $0.20 (+45%).","Implemented providers up 13.1%, practice collections up 27.1% year over year in Q3.","Adjusted EBITDA grew 61.6%; FY2025 guidance raised above high end for all key operating and financial metrics."],"consensus_eps_estimate":null,"consensus_eps_actual":0.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":1581669000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124604,"accession_number":"0001759655-25-000104","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2025-10-28T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Privia Health board member Patricia Maryland passes away","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Patricia Maryland, Board member and Chair of the Compliance Committee, died on Oct 24, 2025.","She served on the board for over five years and chaired the Compliance Committee.","No replacement has been announced at this time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141277,"accession_number":"0001759655-25-000099","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2025-09-23T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Privia Health to acquire Evolent Health's ACO business for $100M cash, up to $113M with earnout","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquires Evolent Health's ACO business covering over 120,000 attributed lives in MSSP and commercial MA programs.","Purchase price of $100M in cash at closing, plus up to $13M contingent on 2025 MSSP performance.","Deal expected to close in Q4 2025; expected to positively contribute to Adjusted EBITDA in 2026.","Privia Health will now serve approximately 1.5 million attributed lives in value-based care arrangements.","Acquisition financed with cash on hand; expands VBC footprint into new states and adds provider synergy opportunities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141276,"accession_number":"0001759655-25-000096","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2025-08-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Privia Health reports $233M MSSP savings, raises 2025 EBITDA guidance to $113-116M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Privia Health ACOs generated $233.1 million in Medicare Shared Savings Program savings for 2024, a 32% increase from 2023.","Mid-Atlantic ACO achieved a 10.6% savings rate, the highest among all MSSP ACOs with over 40,000 attributed beneficiaries.","Company raised full-year 2025 Adjusted EBITDA guidance to $113-$116 million due to 2024 MSSP performance.","Privia's nine ACOs delivered a 9.3% aggregate savings rate across 194,700 Medicare beneficiaries and 3,280 providers.","Beneficiary expenditures were 8% below the median ACO and 22% below fee-for-service Medicare in 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141275,"accession_number":"0001759655-25-000091","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Privia Health Q2 revenue $521.2M (+23% YoY); guidance raised above prior range","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $521.2M, up 23.4% YoY; adjusted net income $30.6M ($0.24 EPS) vs $23.5M ($0.19 EPS) YoY.","Implemented providers grew 13.8%; practice collections rose 18.5% compared to Q2 2024.","Company raised full-year guidance above the high end for practice collections, GAAP revenue, platform contribution, and adjusted EBITDA.","Operating income $3.3M (down 34.6% YoY) reflecting $18.8M non-cash stock comp; net income $2.7M.","Cash flow from operations $47.0M for first half 2025 versus $39.9M in first half 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":1001250000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141274,"accession_number":"0001759655-25-000080","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2025-07-08T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Privia Health appoints Lance Berberian to board, adds tech and cybersecurity expertise","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed Lance Berberian to Class III director, effective July 15, 2025; board expands to 10 members.","Berberian brings 30+ years tech strategy experience, most recently EVP & CIO at Labcorp Holdings (NYSE: LH).","Will receive annual cash retainer per non-employee director plan and $200K initial RSU grant prorated.","Also named to Audit Committee; qualifies as independent under Nasdaq rules."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159085,"accession_number":"0001759655-25-000056","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2025-05-22T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Privia Health stockholders approve all three proposals at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Directors Pamela Kimmet, Patricia Maryland, Shawn Morris elected with >102M votes each; broker non-votes ~4.8M.","Advisory say-on-pay approved: 105.1M for, 1.4M against, 41.6K abstentions.","Ratification of PwC as auditor for FY2025: 111.3M for, 18.5K against, 35.9K abstentions.","All proposals passed with strong majority; no material controversy noted."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159084,"accession_number":"0001759655-25-000048","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Privia Health Q1 revenue up 15.6% to $480M; raises full-year outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $480.1M (+15.6% YoY); GAAP net income $4.2M, GAAP EPS $0.03.","Non-GAAP adjusted net income $27.8M (+23.3%); adjusted EPS $0.22 (+22.2%).","Operating income surged to $5.2M from $0.8M a year ago, a 534% increase.","Full-year 2025 guidance raised to mid-to-high end of ranges for all metrics; attributed lives unchanged.","Expanded into Arizona with a new partnership, adding a seventh state to its network."],"consensus_eps_estimate":null,"consensus_eps_actual":0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":480097000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177530,"accession_number":"0001759655-25-000023","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2025-03-07T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Privia Health amends CEO Parth Mehrotra's compensation; base salary $650K, bonus 125%, LTI target $8M","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Base salary increases to $650,000 effective March 24, 2025.","Annual bonus eligibility raised to 125% of base salary starting with 2025 performance year.","Target long-term incentive award set at $8,000,000 for 5-year equity grants.","Amendment effective March 3, 2025; no change to other employment terms.","No Good Reason triggered; changes voluntary per filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177529,"accession_number":"0001759655-25-000016","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Privia Health beats FY2024 guidance: revenue $1.74B, adj EPS $0.78, cash $491M, no debt","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2024 revenue $1,736.4M (+4.7% YoY), gross profit $397.7M (+12.4%), net income $14.4M (-37.7%).","Non-GAAP adjusted net income $97.6M (+19.8%), adjusted EPS $0.78 (+21.9%); cash from ops $109.3M (+35.3%).","Implemented providers +11.2% y/y; cash balance $491.1M, no debt; all 2024 metrics above high end of guidance.","2025 guidance reflects continued momentum; management notes challenging Medicare Advantage environment."],"consensus_eps_estimate":null,"consensus_eps_actual":0.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":1736390000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177528,"accession_number":"0001759655-25-000004","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2025-01-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Privia Health furnishes investor slides at J.P. Morgan conference; no material updates disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Furnished investor presentation for J.P. Morgan 2025 Healthcare Conference on January 13, 2025.","Presentation slides available on ir.priviahealth.com; no specific financial guidance or numbers provided in filing.","No new earnings, M&A, leadership changes, or other material events reported."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194246,"accession_number":"0001759655-24-000129","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Privia Health raises FY2024 guidance, Q3 adjusted EPS $0.20, revenue $437.9M, up 4.9%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $437.9M (+4.9% YoY); gross profit $99.9M (+10.2%); operating income $5.8M (+5.0%).","Non-GAAP adjusted net income $25.1M (+19% YoY); adjusted EPS $0.20 (+17.6%).","Raised full-year 2024 guidance to at or above high end for all financial metrics.","Announced new market entry in Indiana; MSSP 2023 shared savings $176.6M, up 34.1% YoY.","Net income $3.5M (down 37.4%) due to $15.1M non-cash stock compensation expense."],"consensus_eps_estimate":null,"consensus_eps_actual":0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":1275490000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210575,"accession_number":"0001759655-24-000115","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Privia Health Q2 revenue up 2.2% to $422.3M; raises FY2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 GAAP net income $3.5M ($0.03 EPS); adjusted net income $23.5M ($0.19 EPS), +13% YoY.","Practice partners increased 15% YoY to 5,500; care center locations up 4% to 1,340.","Gross profit rose 8.9% to $98.3M; operating income fell 27% to $5.1M on higher stock compensation.","Raised full-year 2024 guidance: revenue $1.685-1.715B, adjusted EBITDA $117-122M, adj. EPS $0.66-0.71.","Net cash provided by operations was $38.6M YTD; free cash flow was $30.5M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":837569000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210574,"accession_number":"0001759655-24-000110","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2024-07-03T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Privia Health director Bill Sullivan resigns from Board and Audit Committee","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Bill Sullivan resigned from the Board and Audit Committee effective July 1, 2024.","Resignation not due to any disagreement with the Company on operations, policies, or practices.","Board and Management thanked Mr. Sullivan for his service."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228908,"accession_number":"0001759655-24-000106","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2024-06-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Privia Health furnishes investor presentation at William Blair conference; no material new information","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Presentation provided at William Blair 44th Annual Growth Stock Conference on June 5, 2024.","No updated financial guidance, metrics, or material events were disclosed in the filing.","The presentation is available on the company's investor relations website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228905,"accession_number":"0001759655-24-000099","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K/A","filed_at":"2024-05-29T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Privia Health corrects overstated vote against advisory executive compensation proposal","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Amendment corrects Proposal 2 vote: 96,616,303 For, 2,663,618 Against, 4,660,430 Abstentions.","Original 8-K overstated Votes Against for advisory say-on-pay; restated as above.","All five proposals approved at May 22 annual meeting; director election, auditor ratification, charter amendments passed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228907,"accession_number":"0001759655-24-000076","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2024-05-23T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Privia Health shareholders approve removal of supermajority voting and officer exculpation amendments","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Approved Second Amended Restated Charter removing supermajority voting provisions and limiting officer liability under Delaware law.","Elected four Class II directors: Thomas McCarthy, Parth Mehrotra, Dr. Jaewon Ryu, William Sullivan.","Advisory vote approved named executive officer compensation with 96.6M for, 26.7M against.","Ratified PricewaterhouseCoopers as independent auditor for fiscal 2024 with 110.1M for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228906,"accession_number":"0001759655-24-000050","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Privia Health Q1 revenue +7.5% to $415M; GAAP net income down 59% but adjusted EPS up 12.5%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $415.2M (+7.5% YoY); Practice Collections +7.4%; Implemented Providers +17.3%.","GAAP net income $3.0M ($0.03 EPS) vs $7.3M ($0.06 EPS) in Q1'23; includes $11.9M stock comp.","Non-GAAP adjusted net income $22.5M ($0.18 EPS) vs $19.3M ($0.16 EPS), +16.6% and +12.5% per share.","Operating income fell 87.7% to $0.8M from $6.7M year-over-year.","Company reiterated full year 2024 guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":415243000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247549,"accession_number":"0001759655-24-000019","cik":1759655,"company_name":"Privia Health Group, Inc.","ticker":"PRVA","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Privia Health FY2023 revenue up 22.2% to $1,657.7M, adjusted EPS $0.64; introduces 2024 outlook","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Full-year revenue $1,657.7M (up 22.2% YoY); net income $23.1M vs loss $8.6M in 2022.","Non-GAAP adjusted net income $81.5M (up 27.9%); adjusted EPS $0.64 vs $0.52.","Implemented providers grew 19.4% from year-end 2022; achieved all 2023 operating and financial guidance metrics.","Introduced full-year 2024 guidance; management taking proactive steps to limit downside risk in Medicare Advantage."],"consensus_eps_estimate":null,"consensus_eps_actual":0.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":1657737000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2760301042.635925,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}